Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival
Authors:
- 1 June 1997
- journal article
- Published by Elsevier in Human Pathology
- Vol. 28 (6) , 686-692
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasInternational Journal of Cancer, 1995
- c‐crbB2 gene amplification and protein expression in ovarian epithelial tumors: Evaluation of their respective prognostic significance by multivariate analysisInternational Journal of Cancer, 1995
- Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaCancer, 1995
- Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.Journal of Clinical Oncology, 1995
- Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based ChemotherapyGynecologic Oncology, 1994
- Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.Journal of Clinical Pathology, 1994
- Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stageCancer, 1994
- Clinical significance of cathepsin D in primary ovarian cancerEuropean Journal of Cancer, 1994
- p53 accumulation in ovarian carcinomas and its prognostic implicationsHuman Pathology, 1993
- Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survivalAmerican Journal of Obstetrics and Gynecology, 1993